Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on Indian Patient Experience on Adalimumab
Adalimumab, a widely used biologic for treating various autoimmune conditions, has garnered positive feedback from Indian patients for its efficacy in managing diseases such as rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Patients report significant improvements in symptom relief, including reduced pain, swelling, and skin lesions, leading to enhanced quality of life. This biologic’s ability to provide rapid and sustained symptom control has been particularly appreciated, allowing patients to regain mobility and participate more actively in daily activities.
However, the high cost of adalimumab remains a significant barrier for many Indian patients, limiting its accessibility despite its proven benefits. To address this issue, the introduction of biosimilars has provided a more affordable alternative, increasing the number of patients who can benefit from this treatment. Patients using biosimilar versions have reported similar therapeutic outcomes, making these options a valuable addition to the treatment landscape in India.
Therefore, get an overall knowledge of indian patient experience on adalimumab
See More Webinars @ Hidoc Webinars
1.
First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC
2.
Children with rare gliomas have new hope thanks to clinical trial results.
3.
GLP-1 receptor agonists, cancer risk and questionable significance
4.
Global inequalities found in cancer research funding
5.
According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.
1.
Innovative Advances in Oncology for Specialists
2.
Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics
3.
Extracellular Protein Signatures of Megakaryocyte Activation
4.
Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System
5.
Exploring the Potential of Bendamustine in Cancer Treatment
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
3.
Understanding the Importance of Follow-Up After Cancer Treatment
4.
Understanding the Role of Screening in Cancer Prevention
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation